Neoadjuvant Immune Checkpoint Inhibitor plus Chemotherapy for Resectable Non-small Cell Lung Cancer in Real World

被引：0
|
作者：
Chen, C. [1 ]
机构：
[1] Zunyi Med Univ, Affiliated Hosp, Zunyi, Guizhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Non-small cell lung cancer; Neoadjuvant therapy; PD-1; inhibitor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-24
引用
收藏
页码：S579 / S580
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Zhang, Ran
    Zhao, Gang
    You, Jian
    HELIYON, 2023, 9 (09)
  • [2] Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer
    Riano, Ivy
    Abuali, Inas
    Sharma, Aditya
    Durant, Jewelia
    Dragnev, Konstantin H. H.
    PHARMACEUTICALS, 2023, 16 (02)
  • [3] Real-world evidence of advanced non-small cell lung carcinoma treated with an immune checkpoint inhibitor plus chemotherapy
    Xu, Zihan
    Zhang, Huien
    Ma, Guikai
    Meng, Wenjuan
    Du, Junliang
    Wu, Xin
    Yang, Baohong
    Wang, Ningning
    Ding, Yanhong
    Zhang, Qingyun
    Li, Na
    Zhang, Xuede
    Yu, Guohua
    Liu, Shuzhen
    Li, Zhenhua
    ONCOLOGY LETTERS, 2024, 28 (03)
  • [4] A real-world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non-small cell lung cancer
    Zhang, Baihua
    Xiao, Haifan
    Pu, Xingxiang
    Zhou, Chunhua
    Yang, Desong
    Li, Xu
    Wang, Wenxiang
    Xiao, Qin
    CANCER MEDICINE, 2023, 12 (01): : 274 - 286
  • [5] Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    Xue, Chongxiang
    Dong, Huijing
    Chen, Ying
    Lu, Xingyu
    Zheng, Shuyue
    Cui, Huijuan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 779 - 788
  • [6] Real-world clinical outcomes of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer
    Wu, Junqi
    Hou, Likun
    Zhao, Yue
    Yu, Xin
    Xu, Long
    Ning, Ye
    Deng, Jiajun
    Sun, Ke
    Zhang, Jie
    Wu, Chunyan
    Zhu, Yuming
    Zhao, Deping
    She, Yunlang
    Su, Chunxia
    Chen, Chang
    Haoran, E.
    LUNG CANCER, 2022, 165 : 115 - 123
  • [7] Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer
    Lochrin, Sarah E.
    Forde, Patrick M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (08) : 415 - 423
  • [8] Comparison of neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable stage III non-small cell lung cancer: a real-world cohort study
    Zhou, Sihao
    Liu, Yi
    Liu, Kejun
    Zhang, Junkai
    Liang, Hanlin
    Wu, Yingmeng
    Ye, Hongyu
    Liang, Yi
    Zhang, Jingjing
    Huang, Weizhao
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [9] Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer
    Tang, Monica
    Lee, Chee K.
    Lewis, Craig R.
    Boyer, Michael
    Brown, Bernadette
    Schaffer, Andrea
    Pearson, Sallie-Anne
    Simes, Robert J.
    LUNG CANCER, 2022, 166 : 40 - 48
  • [10] Neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Xie, Hui
    Shi, Xuejun
    Wang, Guangshun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 2521 - 2536
12345